Home » Topics » Regulatory » EMA

EMA
RSS

Positive opinion for new Thyrogen indication in Europe

Jan. 27, 2005

EMEA warns on new safety findings for valdecoxib, parecoxib sodium

Dec. 27, 2004

EMEA warns on coadministration of Reyataz and Norvir with omeprazole

Dec. 27, 2004

CHMP adopts extension of indication for Schering-Plough HCV products

Oct. 27, 2004

E.U. regulators to review long-term cardiovascular safety data for COX-2 inhibitors

Oct. 13, 2004

March 2004 meeting of European Committee for Orphan Medicinal Products

March 24, 2004

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...